PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer (2016)
- Authors:
- USP affiliated authors: SAGGIORO, FABIANO PINTO - SVOI ; SQUIRE, JEREMY ANDREW - FMRP
- Unidades: SVOI; FMRP
- Subjects: NEOPLASIAS PROSTÁTICAS; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Publisher: Queen's University
- Publisher place: Ontario
- Date published: 2016
- Source:
- Título: Abstracts
- Conference titles: Cancer Genomics Group Meetings
-
ABNT
VIDOTTO, Thiago et al. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. 2016, Anais.. Ontario: Queen's University, 2016. . Acesso em: 12 fev. 2026. -
APA
Vidotto, T., Ouellet, V., Saggioro, F. P., Caron, C., Fragoso, G., Mes-Masson, A. -M., et al. (2016). PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. In Abstracts. Ontario: Queen's University. -
NLM
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2026 fev. 12 ] -
Vancouver
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2026 fev. 12 ] - Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
- ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer
- A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- Extracellular vesicles: evolving factors in stem cell biology
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
